Encainide for refractory ventricular tachyarrhythmia.
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D000813:Anilides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004594:Electrophysiology; D016700:Encainide; D005080:Exercise Test; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D009325:Nausea / Q000139:chemically induced; D012306:Risk; D013610:Tachycardia / Q000188:drug therapy*; D014693:Ventricular Fibrillation / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D016700:Encainide